GH21-003, Advancing Public Health Research in Kenya

GH21-003,推进肯尼亚的公共卫生研究

基本信息

  • 批准号:
    10472398
  • 负责人:
  • 金额:
    $ 742.7万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-30 至 2026-09-29
  • 项目状态:
    未结题

项目摘要

SUMMARY (ADMINISTRATIVE CORE) Our Consortium consisting of Washington State University (WSU), the Liverpool School of Tropical Medicine (LSTM), and the Kenya Medical Research Institute (KEMRI) proposes to support KEMRI to develop and manage a highly cost-effective and sustainable KEMRI/CGHR Research Platform (KRP) in western Kenya (under “Category 1. Research Coordination and Administration” of the administrative core). The platform includes the population-based health and demographic surveillance systems, laboratories in Kisumu and Nairobi, clinical research centers in Kisumu, and offices and shared services at the Kisian campus, Kisumu. Between 2014 and 2020, KRP’s day-to-day management was changed three times to make it more efficient, transparent, affordable, and less contentious with KEMRI, CDC, and other partners. Currently, the platform is managed by KEMRI, with CDC (through its partners) contributing financially together with the other international partners who share the platform. WSU and LSTM have an excellent relationship with KEMRI and its partners and many years of administrative and technical expertise in Kenya. Following extensive discussions and agreements leading up to this joint application, WSU, LSTM, and KEMRI central leadership will support KEMRI/CGHR to implement a management plan to strengthen the Center’s capacity to assume cost-effective and sustainable management of the platform in support of their public health research in Kenya. This will include a phased introduction of financial and administrative management systems, mutually agreed systems for cost-sharing across all national and international partners sharing the facilities, close fiscal oversight by WSU, and mentorship and training. KEMRI has already taken critical steps to streamline the platform’s management and strengthen its leadership, including the appointment of three senior staff at KEMRI/CGHR, the revision of policies to enhance decision-making at the Center level, and commitment to providing its share of financial support. It also includes the rolling out of an electronic system for the management of grant and ethics applications. As part of “Category 2. Research Laboratory Administration”, we will maintain accreditation standards, quality assurance processes, and integrated biosafety and biosecurity systems to support KEMRI state-of-the-art laboratories. We will also introduce a laboratory information management system, including for effective management of samples and associated data. The KEMRI laboratories recently demonstrated their utility to the country by providing >70% of the country’s testing capacity for COVID-19 pandemic. In addition, we present evident technical expertise to lead the Research Core areas identified in the RFA, including HIV and TB, malaria, influenza, and other respiratory pathogens, zoonotic diseases, antimicrobial resistance, neglected tropical diseases, non-communicable diseases, and vaccine- preventable diseases. Experienced WSU and LSTM scientists will team up with KEMRI and CDC counterparts to design, implement, and publish research, an approach designed to train and mentor KEMRI scientists in applying and managing research funding. In the accompanying Research Core proposals, these teams describe field and laboratory activities that address each required outcome and objective of the RFA. Table 5 of this Administrative Core provides a work plan showing how each study will be implemented over the program’s 5-year duration.
摘要(行政核心)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

M KARIUKI NJENGA其他文献

M KARIUKI NJENGA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('M KARIUKI NJENGA', 18)}}的其他基金

GH21-003, Advancing Public Health Research in Kenya
GH21-003,推进肯尼亚的公共卫生研究
  • 批准号:
    10893917
  • 财政年份:
    2021
  • 资助金额:
    $ 742.7万
  • 项目类别:
Emerging Infectious Diseases Research Center - East and Central Africa
新发传染病研究中心 - 东非和中非
  • 批准号:
    10464357
  • 财政年份:
    2021
  • 资助金额:
    $ 742.7万
  • 项目类别:
GH21-003, Advancing Public Health Research in Kenya
GH21-003,推进肯尼亚的公共卫生研究
  • 批准号:
    10630848
  • 财政年份:
    2021
  • 资助金额:
    $ 742.7万
  • 项目类别:
GH21-003, Advancing Public Health Research in Kenya
GH21-003,推进肯尼亚的公共卫生研究
  • 批准号:
    10693978
  • 财政年份:
    2021
  • 资助金额:
    $ 742.7万
  • 项目类别:
GH21-003, Advancing Public Health Research in Kenya
GH21-003,推进肯尼亚的公共卫生研究
  • 批准号:
    10352815
  • 财政年份:
    2021
  • 资助金额:
    $ 742.7万
  • 项目类别:
GH21-003, Advancing Public Health Research in Kenya
GH21-003,推进肯尼亚的公共卫生研究
  • 批准号:
    10820145
  • 财政年份:
    2021
  • 资助金额:
    $ 742.7万
  • 项目类别:
Emerging Infectious Diseases Research Center - East and Central Africa
新发传染病研究中心 - 东非和中非
  • 批准号:
    10171768
  • 财政年份:
    2020
  • 资助金额:
    $ 742.7万
  • 项目类别:
Emerging Infectious Diseases Research Center - East and Central Africa
新发传染病研究中心 - 东非和中非
  • 批准号:
    10427187
  • 财政年份:
    2020
  • 资助金额:
    $ 742.7万
  • 项目类别:
Emerging Infectious Diseases Research Center - East and Central Africa
新发传染病研究中心 - 东非和中非
  • 批准号:
    10649662
  • 财政年份:
    2020
  • 资助金额:
    $ 742.7万
  • 项目类别:
GH16-006: Conducting Communicable Disease Research in Kenya
GH16-006:在肯尼亚进行传染病研究
  • 批准号:
    9341941
  • 财政年份:
    2016
  • 资助金额:
    $ 742.7万
  • 项目类别:

相似国自然基金

基于JAK-STAT信号通路研究E003调控URSA的Th17/Treg免疫平衡的分子机制
  • 批准号:
    82360318
  • 批准年份:
    2023
  • 资助金额:
    31.00 万元
  • 项目类别:
    地区科学基金项目
噬菌体PaoP5编码蛋白Orf003通过FleQ抑制铜绿假单胞菌运动的分子机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
HSP47抑制剂Col003抗血小板作用机制及其对大鼠脑缺血再灌注损伤影响的研究
  • 批准号:
    82160236
  • 批准年份:
    2021
  • 资助金额:
    34 万元
  • 项目类别:
    地区科学基金项目
缺血预处理诱导的tiRNA-Gly-GCC-003 在急性肾损伤中的保护作用及机制研究
  • 批准号:
    2021JJ40954
  • 批准年份:
    2021
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
PCSK9Qβ-003疫苗通过非LDLR代谢途径防治动脉粥样硬化
  • 批准号:
    81900401
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
PCSK9Qβ-003降脂疫苗抑制肾脏纤维化的机制研究
  • 批准号:
    81900459
  • 批准年份:
    2019
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
SNHG6-003调控外泌体促进肝癌细胞侵袭转移的分子机制
  • 批准号:
    81872399
  • 批准年份:
    2018
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
砷氧化菌CRS003对稻田土壤中砷的形态转化和迁移的影响机制
  • 批准号:
    21677033
  • 批准年份:
    2016
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
长链非编码RNA uc003zpr.2通过PCP4途径调节醛固酮分泌的机制研究
  • 批准号:
    81670727
  • 批准年份:
    2016
  • 资助金额:
    51.0 万元
  • 项目类别:
    面上项目
长链非编码RNA AC006050.3-003调控肺鳞癌顺铂化疗敏感性及其机制研究
  • 批准号:
    81572937
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

CE23-003 - Taking A Public Health Perspective on Human Trafficking: An Evaluation of the PROTECT Prevention Program
CE23-003 - 从公共卫生角度看待人口贩运:PROTECT 预防计划的评估
  • 批准号:
    10760022
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
CE23-003 - Caregiver Relational Responsiveness (RR): An Understudied Fidelity Construct as a Mechanism to Increase Protective Factors Against Maltreatment.
CE23-003 - 照顾者关系响应 (RR):一种未经充分研究的忠诚度结构,作为增加针对虐待的保护因素的机制。
  • 批准号:
    10759625
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
RFA-GH-23-003, THAI-GER: THAIland Genomic surveillance of Emerging infectious diseases facilitating Rapid response
RFA-GH-23-003,THAI-GER:泰国对新发传染病的基因组监测促进快速反应
  • 批准号:
    10980415
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
RFA-GH-23-003, THAI-GER: THAIland Genomic surveillance of Emerging infectious diseases facilitating Rapid response
RFA-GH-23-003,THAI-GER:泰国对新发传染病的基因组监测促进快速反应
  • 批准号:
    10808039
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
CE23-003 - A multi-level examination of social safety net accessibility as a modifiable structural condition contributing to violence against children
CE23-003 - 对社会安全网的可及性进行多层次审查,将其作为导致暴力侵害儿童行为的可修改结构条件
  • 批准号:
    10759248
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
Development Core-003
开发核心-003
  • 批准号:
    10660386
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
PS23-003 - A Community-based Assessment of Preferences for Long-Acting Antiretroviral Therapy Options Among Cis-gender Black Women across Six Ending the HIV Epidemic Jurisdictions in the South
PS23-003 - 基于社区的六个顺性别黑人女性对长效抗逆转录病毒治疗方案偏好的评估,结束南方艾滋病毒流行管辖区
  • 批准号:
    10812111
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
Project-003
项目-003
  • 批准号:
    10841222
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
RFA-GH-23-003, THAI-GER: THAIland Genomic surveillance of Emerging infectious diseases facilitating Rapid response
RFA-GH-23-003,THAI-GER:泰国对新发传染病的基因组监测促进快速反应
  • 批准号:
    11001433
  • 财政年份:
    2023
  • 资助金额:
    $ 742.7万
  • 项目类别:
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
RFA-CK-22-003,新发感染哨兵网络 (EISN) 研究 - 2022 年
  • 批准号:
    10516881
  • 财政年份:
    2022
  • 资助金额:
    $ 742.7万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了